doi: 10.1021/jm061072p.
Design, synthesis, and biological evaluation of phenylamino-substituted 6,11-dihydro-dibenzo[b,e]oxepin-11-ones and dibenzo[a,d]cycloheptan-5-ones: novel p38 MAP kinase inhibitors
Affiliations
- PMID: 17181176
- DOI: 10.1021/jm061072p
Item in Clipboard
Design, synthesis, and biological evaluation of phenylamino-substituted 6,11-dihydro-dibenzo[b,e]oxepin-11-ones and dibenzo[a,d]cycloheptan-5-ones: novel p38 MAP kinase inhibitors
J Med Chem.
.
Abstract
The pathogenesis of chronic inflammatory diseases is promoted by various pro-inflammatory cytokines. p38 MAP kinase seems to be a valid target as it controls proinflammatory cytokine levels on both transcriptional and translational levels. Starting from benzophenone-type inhibitors, a rigidisation strategy lead to 3-amino-6,11-dihydro-dibenzo[b,e]thiepin-11-one, phenylamino-substituted 6,11-dihydro-dibenzo[b,e]oxepin-11-ones, and dibenzo[a,d]cyclohepten-5-ones. Synthesis, p38 inhibition, and CYP-inhibition of selected compounds are described.
Similar articles
-
Design, synthesis and SAR of phenylamino-substituted 5,11-dihydro-dibenzo[a,d]cyclohepten-10-ones and 11H-dibenzo[b,f]oxepin-10-ones as p38 MAP kinase inhibitors.Bioorg Med Chem Lett. 2010 May 15;20(10):3074-7. doi: 10.1016/j.bmcl.2010.03.107. Epub 2010 Apr 1. Bioorg Med Chem Lett. 2010. PMID: 20418099
-
Design, synthesis, and biological evaluation of novel Tri- and tetrasubstituted imidazoles as highly potent and specific ATP-mimetic inhibitors of p38 MAP kinase: focus on optimized interactions with the enzyme's surface-exposed front region.J Med Chem. 2008 Jul 24;51(14):4122-49. doi: 10.1021/jm701529q. Epub 2008 Jun 26. J Med Chem. 2008. PMID: 18578517
-
Novel lead structures for p38 MAP kinase via FieldScreen virtual screening.J Med Chem. 2009 Jul 23;52(14):4200-9. doi: 10.1021/jm801399r. J Med Chem. 2009. PMID: 19489590
-
Novel strategies for inhibition of the p38 MAPK pathway.Trends Pharmacol Sci. 2007 Jun;28(6):286-95. doi: 10.1016/j.tips.2007.04.008. Epub 2007 May 7. Trends Pharmacol Sci. 2007. PMID: 17482683 Review.
-
p38 MAPK as a potential therapeutic target for inflammatory osteolysis.Adv Anat Pathol. 2007 Jan;14(1):42-5. doi: 10.1097/PAP.0b013e31802ef4f2. Adv Anat Pathol. 2007. PMID: 17198310 Review.
Cited by
-
C-H bond functionalization via hydride transfer: formation of α-arylated piperidines and 1,2,3,4-tetrahydroisoquinolines via stereoselective intramolecular amination of benzylic C-H bonds.J Org Chem. 2012 Aug 17;77(16):6689-702. doi: 10.1021/jo300635m. Epub 2012 Jun 6. J Org Chem. 2012. PMID: 22672002 Free PMC article.
-
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.Nat Chem Biol. 2011 Dec 25;8(2):141-3. doi: 10.1038/nchembio.761. Nat Chem Biol. 2011. PMID: 22198732
-
N-{2-Methyl-5-[(5-oxo-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-2-yl)amino]-phen-yl}benzamide.Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 30;66(Pt 7):o1867. doi: 10.1107/S1600536810024256. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21588064 Free PMC article.
-
Applications of Friedel-Crafts reactions in total synthesis of natural products.RSC Adv. 2018 Dec 3;8(70):40061-40163. doi: 10.1039/c8ra07325b. eCollection 2018 Nov 28. RSC Adv. 2018. PMID: 35558228 Free PMC article. Review.
-
N-[3-(5-Oxo-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-2-ylamino)phen-yl]furan-3-carboxamide.Acta Crystallogr Sect E Struct Rep Online. 2010 Apr 17;66(Pt 5):o1100. doi: 10.1107/S1600536810013450. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21579152 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
